H. J. Ehrlich

676 citations

14 papers · 555 indexed · h-index 11

Impact in

Hematology top 2%
- Blood Coagulation and Thrombosis Mechanisms
- Hemophilia Treatment and Research
- Platelet Disorders and Treatments
Cancer Research top 10%
- Protease and Inhibitor Mechanisms

Papers in ⓘ

Hematology 12
- Platelet Disorders and Treatments 7
- Blood Coagulation and Thrombosis Mechanisms 7
- Hemophilia Treatment and Research 4
- Blood groups and transfusion 2
Cancer Research 5
- Protease and Inhibitor Mechanisms 5

Co-authors: M Linders (3 shared papers)Hans Pannekoek (3 shared papers)Jaap Keijer (3 shared papers)Raymond Klein Gebbink (2 shared papers)Klaus T. Preissner (1 shared paper)Nils U. Bang (5 shared papers)I. Scharrer (2 shared papers)S. Richard Jaskunas (3 shared papers)
Journals: Haemophilia (3 papers)Journal of Biological Chemistry (2 papers)The EMBO Journal (1 paper)Journal of Allergy and Clinical Immunology (1 paper)Proceedings of the National Academy of Sciences (1 paper)
Partner nations: Austria United States Germany

In The Last Decade

H. J. Ehrlich

14 papers receiving 527 citations

Peers

Countries citing papers authored by H. J. Ehrlich

Since Specialization

Citations

This map shows the geographic impact of H. J. Ehrlich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. J. Ehrlich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. J. Ehrlich more than expected).

Fields of papers citing papers by H. J. Ehrlich

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. J. Ehrlich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. J. Ehrlich. The network helps show where H. J. Ehrlich may publish in the future.

Co-authors

The 25 scholars most cited alongside H. J. Ehrlich, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with H. J. Ehrlich Line = papers co-authored together H. J. Ehrlich links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

#	Work
1	Alteration of serpin specificity by a protein cofactor. Vitronectin endows plasminogen activator inhibitor 1 with thrombin inhibitory properties. Journal of Biological Chemistry ·H. J. Ehrlich, Raymond Klein Gebbink, Jaap Keijer, M Linders, Klaus T. Preissner, Hans Pannekoek	1990	142
2	BAX 855, a PEGylated rFVIII product with prolonged half-life. Development, functional and structural characterisation. PubMed ·Peter L. Turecek, M.J. Bossard, Michael Graninger, Herbert Gritsch, Werner Höllriegl, Martin Kaliwoda, Peter Matthiessen, Artur Mitterer, E‐M Muchitsch, Martin Purtscher, Hanspeter Rottensteiner, Alexandra Schiviz, Gerald Schrenk, J. Siekmann, Katalin Váradi, Thomas N. Riley, H. J. Ehrlich, H. P. Schwarz, Friedrich Scheiflinger	2012	86
3	The interaction of plasminogen activator inhibitor 1 with plasminogen activators (tissue-type and urokinase-type) and fibrin: localization of interaction sites and physiologic relevance Blood ·Jaap Keijer, M Linders, AJ van Zonneveld, H. J. Ehrlich, JP de Boer, Hans Pannekoek	1991	85
4	Recombinant human protein C derivatives: altered response to calcium resulting in enhanced activation by thrombin. The EMBO Journal ·H. J. Ehrlich, Brian W. Grinnell, S. Richard Jaskunas, CT Esmon, S. Betty Yan, Nils U. Bang	1990	41
5	Prospective open‐label study of pharmacokinetics, efficacy and safety of a new 10% liquid intravenous immunoglobulin in patients with hypo‐ or agammaglobulinemia Vox Sanguinis ·Janne Björkander, J Nikoskelainen, Heinz Leibl, Peter Lanbeck, Jonas Wallvik, J. T. Lumio, Jean Henrik Braconier, B. G. Pavlova, K. Birthistle, Werner Engl, Simone Walter, H. J. Ehrlich	2006	40
6	Vitamin K-dependent carboxylase: possible role of the substrate "propeptide" as an intracellular recognition site. Proceedings of the National Academy of Sciences ·John W. Suttie, JoAnn Hoskins, J. Engelke, A Hopfgartner, H. J. Ehrlich, Nils U. Bang, Rama M. Belagaje, Brigitte Schoner, George L. Long	1987	36
7	Biological properties of a kringleless tissue plasminogen activator (t-PA) mutant Fibrinolysis and Proteolysis ·H. J. Ehrlich, Nils U. Bang, Sharon Little, S. Richard Jaskunas, Benjamin Weigel, L.E. Mattler, Cathy S. Harms	1987	33
8	Lack of evidence for increased inhibitor incidence in patients switched from plasma-derived to recombinant factor VIII Haemophilia ·I. Scharrer, H. J. Ehrlich	2001	24
9	Direct Expression of Recombinant Activated Human Protein C, a Serine Protease Journal of Biological Chemistry ·H. J. Ehrlich, S. Richard Jaskunas, Brian W. Grinnell, S. Betty Yan, Nils U. Bang	1989	22
10	Stabilisation of plasminogen activator inhibitor type 1 (PAI-1) activity by arginine: Possible implications for the interaction of PAI-1 with vitronectin Fibrinolysis and Proteolysis ·Jaap Keijer, M Linders, H. J. Ehrlich, Raymond Klein Gebbink, Hans Pannekoek	1990	17
11	Evaluation of pharmacokinetics, efficacy and safety of Immunate^® solvent detergent in previously treated patients with severe haemophilia A Haemophilia ·László Nemes, Toshko Lissitchkov, Anna Klukowska, Grzegorz Dobaczewski, V. Komrska, R. Zimmermann, G. Auerswald, Werner Engl, Borislava G. Pavlova, Brigitt Abbühl, H. J. Ehrlich	2006	10
12	Lack of evidence for increased inhibitor incidence in patients switched from plasma‐derived to recombinant factor VIII Haemophilia ·I. Scharrer, H. J. Ehrlich	2001	10
13	In vivo behavior of detergent-solubilized purified rabbit thrombomodulin on intravenous injection into rabbits. PubMed ·H. J. Ehrlich, N L Esmon, Nils U. Bang	1990	8
14	Anti-Fas antibodies in IVIG products and in healthy blood donors Journal of Allergy and Clinical Immunology ·M. T. Stellamor, H. P. Schwarz, H. J. Ehrlich, Katharina Zimmermann, Friedrich Scheiflinger, Birgit M. Reipert	2004	1

About H. J. Ehrlich

H. J. Ehrlich is a scholar working on Hematology, Cancer Research, Genetics, Molecular Biology and Pulmonary and Respiratory Medicine, having authored 14 papers that have together received 555 indexed citations. Recurring topics across this work include Platelet Disorders and Treatments (7 papers), Blood Coagulation and Thrombosis Mechanisms (7 papers), Protease and Inhibitor Mechanisms (5 papers), Hemophilia Treatment and Research (4 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (3 papers), Blood groups and transfusion (2 papers), Vitamin K Research Studies (2 papers) and Blood properties and coagulation (2 papers). The work is most often cited by research in Hematology (423 citations), Cancer Research (233 citations), Immunology and Allergy (63 citations), Genetics (93 citations) and Internal Medicine (12 citations). H. J. Ehrlich has collaborated with scholars based in Austria, United States and Germany. Frequent co-authors include M Linders, Hans Pannekoek, Jaap Keijer, Raymond Klein Gebbink, Klaus T. Preissner, Nils U. Bang, I. Scharrer, S. Richard Jaskunas, Brian W. Grinnell and S. Betty Yan. Their work appears in journals such as Haemophilia, Journal of Biological Chemistry, The EMBO Journal, Journal of Allergy and Clinical Immunology and Proceedings of the National Academy of Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact